364
Participants
Start Date
December 22, 2016
Primary Completion Date
May 28, 2021
Study Completion Date
May 28, 2021
Levonorgestrel IUS (Mirena, BAY86-5028)
Levonorgestrel (LNG) intrauterine delivery system (IUS) with an initial in vitro release rate of 20 μg levonorgestrel per day.
New York
Port Jefferson
Erie
Philadelphia
Philadelphia
Pikesville
Frederick
Midlothian
North Chesterfield
Virginia Beach
Greensboro
Durham
Morehead City
New Bern
Hickory
Asheville
Atlanta
Chattanooga
Mayfield Heights
Fort Wayne
Saginaw
Lincoln
Houston
Austin
Aurora
Idaho Falls
Phoenix
Scottsdale
Tucson
Albuquerque
Las Vegas
Encinitas
Ventura
San Francisco
Portland
Seattle
Seattle
Mobile
Newburgh
Boston
Lebanon
Lawrenceville
Neptune City
Winston-Salem
Franklin
Fort Worth
Draper
Roanoke
Spokane
Lead Sponsor
Bayer
INDUSTRY